Skip to search formSkip to main contentSkip to account menu

onabotulinumtoxinA

Known as: onabotulinum toxin A, onabotulinumtoxin A 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (2)

Botoxvistabel

Broader (1)

Botulinum Toxin Type A
onabotulinumtoxinA 200 UNT Injection

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Does asymptomatic bacteriuria increase the risk of adverse events or modify the efficacy of intradetrusor onabotulinumtoxinA injections?
To assess the impact of asymptomatic bacteriuria (ASB) on the safety and efficacy of intradetrusor onabotulinumtoxinA injections… 
Review
2017
Review
2017
OnabotulinumtoxinA in the treatment of patients with chronic migraine: clinical evidence and experience
Chronic migraine is a debilitating neurobiological disorder that affects approximately 1.4–2.2% of the population worldwide… 
Review
2016
Review
2016
Chronic migraine treatment: from OnabotulinumtoxinA onwards
ABSTRACT Introduction: WHO ranks migraine as the 6th highest cause of disability worldwide when considered alone, and the 3rd… 
2016
2016
Advancements and Refinement in Facial Neuromodulators
Summary: The use of neuromodulators has increased by approximately 748 percent from 2000 to 2014 and has become an integral… 
2014
2014
Comparison between botulinum neurotoxin type A2 and type A1 by electrophysiological study in healthy individuals.
Review
2014
Review
2014
Onabotulinumtoxin A injections: a safety review of children with clubfoot under 2 years of age at BC Children's Hospital.
2013
2013
Muscle Atrophy Beyond the Clinical Effect After a Single Dose of OnabotulinumtoxinA Injected in the Procerus Muscle: A Study with Magnetic Resonance Imaging
Background Botulinum toxin is a powerful and often used agent to treat dynamic rhytides. Focal and reversible neurogenic atrophy… 
Review
2012
Review
2012
[Chronic migraine: definition, epidemiology, risk factors and treatment].
INTRODUCTION Chronic migraine is the most frequent complication of migraine. It is defined by the presence of headache on 15 or… 
Review
2012
Review
2012
Onabotulinum Toxin A (Botox®) in the Treatment of Neurogenic Bladder Overactivity
Botulinum toxin (BT) is a potent presynaptic neuromuscular blocking agent which induces selective, reversible muscle weakness for… 
2012
2012
[Clinical experience of treatment with onabotulinumtoxin A in patients with refractory migraine].
AIM To analyse our experience in the treatment of refractory chronic migraine, episodic frequent refractory migraine (≥10 days… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)